Cargando…

The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma

BACKGROUND: We report a case of a patient with squamous cell carcinoma (SCC) who developed myasthenia gravis (MG), myositis, and myocarditis after receiving cemiplimab, an anti-PD-1 immune checkpoint inhibitor (ICI). Case Presentation. An 86-year-old man with metastatic periocular SCC presented with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeyakumar, Nikeshan, Etchegaray, Mikel, Henry, Jason, Lelenwa, Laura, Zhao, Bihong, Segura, Ana, Buja, L. Maximilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355354/ https://www.ncbi.nlm.nih.gov/pubmed/32695533 http://dx.doi.org/10.1155/2020/5126717

Ejemplares similares

Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023)

Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment
por: Luo, Yue-Bei, et al.
Publicado: (2021)

Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021)

Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single‐center case series
por: Longinow, Joshua, et al.
Publicado: (2022)

Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report
por: Cham, Jason, et al.
Publicado: (2021)

Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma
por: Virgen, Cesar A, et al.
Publicado: (2023)

Terrible triad injuries are no longer terrible! Functional outcomes of terrible triad injuries: a scoping review
por: Stambulic, Thomas, et al.
Publicado: (2022)

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis
por: Kufukihara, Kenji, et al.
Publicado: (2019)

Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Todo, Maki, et al.
Publicado: (2019)

Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review
por: Bai, Jing, et al.
Publicado: (2022)

Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: A life–threatening continuum of neuromuscular and cardiac toxicity
por: Rota, Eugenia, et al.
Publicado: (2018)

Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit
por: Deharo, François, et al.
Publicado: (2022)

Immune Checkpoint Inhibition–Related Myasthenia-Myositis-Myocarditis Responsive to Complement Blockade
por: Nelke, Christopher, et al.
Publicado: (2023)

Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Tomisaki, Ikko
Publicado: (2019)

A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil
por: Jespersen, Mette Syberg, et al.
Publicado: (2021)

Statin-Induced Triad of Autoimmune Myocarditis, Myositis, and Transaminitis
por: Ajmal, Muhammad, et al.
Publicado: (2021)

Thymoma-Associated Myasthenia Gravis With Myocarditis
por: Sarwar, Shihab, et al.
Publicado: (2023)

Myocarditis and myositis/myasthenia gravis overlap syndrome induced by immune checkpoint inhibitor followed by esophageal hiatal hernia: A case report and review of the literature
por: Yin, Beibei, et al.
Publicado: (2022)

Anti-Kv1.4 Antibody Without Myasthenia Gravis: A Rare Cause of Autoimmune Myocarditis and Myositis
por: Kuyama, Naoto, et al.
Publicado: (2023)

Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
por: Fukasawa, Yoko, et al.
Publicado: (2017)

Granulomatous Myositis Associated with Myasthenia Gravis: A Rare Case
por: Iqbal, Shumaila M, et al.
Publicado: (2019)

Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report
por: Zhou, Zhijian, et al.
Publicado: (2019)

Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma
por: Xing, Qian, et al.
Publicado: (2020)

TERRIBLE TRIAD OF THE ELBOW: EVALUATION OF SURGICAL TREATMENT
por: Gomide, Leandro Cardoso, et al.
Publicado: (2015)

Complex Elbow Dislocations and the “Terrible Triad” Injury
por: Jones, Alistair D.R., et al.
Publicado: (2017)

Terrible triad of the elbow: evaluation of surgical treatment()
por: Galbiatti, José Antonio, et al.
Publicado: (2018)

Posterior (Boyd) approach to terrible triad injuries
por: Carroll, Patrick J., et al.
Publicado: (2021)

Terrible triad of the hip: A case report()
por: Alyousif, Hussain, et al.
Publicado: (2021)

A systematic review of myasthenia gravis complicated with myocarditis
por: Cheng, Wei, et al.
Publicado: (2021)

Pembrolizumab‐induced myasthenia gravis with myositis in a patient with lung cancer
por: Hibino, Makoto, et al.
Publicado: (2018)

Result from surgical treatment on the terrible triad of the elbow()
por: de Aquino Santos, Anderson, et al.
Publicado: (2015)

Terrible triad of the elbow: influence of radial head treatment()()
por: Gonçalves, Lucas Braga Jaques, et al.
Publicado: (2014)

TERRIBLE TRIAD OF THE ELBOW: FUNCTIONAL RESULTS OF SURGICAL TREATMENT
por: IKEMOTO, ROBERTO YUKIO, et al.
Publicado: (2017)

An Unusual Case of the “Terrible Triad” in a Transgender Woman
por: Tirthani, Ekta, et al.
Publicado: (2021)

Terrible triad injury of the elbow: a spectrum of theories
por: Laumonerie, Pierre, et al.
Publicado: (2023)

Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer
por: Phua, Chun Seng, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
por: Huang, Yi-Te, et al.
Publicado: (2020)

Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis
por: Verma, Neha, et al.
Publicado: (2021)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Myositis associated to COVID-19 mimics an acute exacerbation in myasthenia gravis patient
por: De Martino, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_243fvdm09ijrrs9sh4le6knaoh